When should alcohol septal ablation be planned for a patient with hypertrophic obstructive cardiomyopathy?

Alcohol Septal Ablation in HOCM: When to Plan the Procedure

Alcohol septal ablation should be planned for adult patients with hypertrophic obstructive cardiomyopathy who have severe drug-refractory symptoms (NYHA class III-IV), a left ventricular outflow tract gradient ≥50 mmHg at rest or with provocation, and adequate septal thickness—but only when surgery is contraindicated or carries unacceptable risk due to serious comorbidities or advanced age. 1

Core Eligibility Requirements

All three criteria must be met simultaneously before planning alcohol septal ablation 2:

1. Clinical Criteria

• Severe symptoms: NYHA functional class III or IV dyspnea or chest pain that interferes with daily activities despite maximized medical therapy (beta-blockers, verapamil, or disopyramide) 1
• Alternative symptoms: Exertional syncope or near-syncope limiting quality of life also qualifies 1, 2
• Drug-refractory status: Patients must have failed optimal doses of negative inotropic medications before consideration 1, 2

2. Hemodynamic Criteria

• LVOT gradient ≥50 mmHg measured at rest or with physiologic provocation (exercise or Valsalva) 1
• Must be associated with septal hypertrophy and systolic anterior motion of the mitral valve 1, 2

3. Anatomic Criteria

• Adequate septal thickness for safe alcohol delivery as judged by the operator 1, 2
• Septal thickness >30 mm is generally discouraged due to uncertain effectiveness 1, 2

Primary Indications by Clinical Context

Class I (Recommended) - Strongest Indication

When surgical myectomy is contraindicated or unacceptably high-risk due to: 1

• Advanced age
• Serious comorbidities (severe pulmonary disease, renal failure, frailty)
• Previous cardiac surgery with hostile mediastinum

Class IIb (May Be Considered) - Alternative Approach

As an alternative to surgical myectomy when: 1

• Patient meets all eligibility criteria
• Patient expresses clear preference for ablation after balanced counseling on risks/benefits of both procedures
• Procedure performed at experienced HCM center

Earlier intervention (NYHA class II) may be reasonable with additional factors: 1, 3

• Severe progressive pulmonary hypertension attributable to LVOTO
• Left atrial enlargement with symptomatic atrial fibrillation episodes
• Poor functional capacity on exercise testing despite LVOTO
• Children/young adults with very high resting gradients (>100 mmHg)

Absolute Contraindications (Class III: Harm)

Never perform alcohol septal ablation in: 1, 2

• Age <21 years (absolute contraindication)
• Adults <40 years when surgical myectomy is feasible (strongly discouraged)
• Asymptomatic patients with normal exercise tolerance
• Patients with well-controlled symptoms on optimal medical therapy
• Concomitant cardiac disease requiring surgery (multivessel CAD needing CABG, intrinsic mitral valve disease requiring repair, severe aortic stenosis) where myectomy could be performed simultaneously 1

Mandatory Center and Operator Requirements

Alcohol septal ablation must only be performed at: 1, 2

• Dedicated HCM centers with comprehensive longitudinal care programs
• Individual operator volume: ≥20 alcohol septal ablations performed cumulatively
• Program volume: ≥50 procedures within the HCM program
• Centers offering multidisciplinary evaluation including both interventional cardiology and cardiac surgery expertise 1, 4

Critical Pitfalls to Avoid

Surgical myectomy remains the first-line option for most eligible patients, particularly younger individuals without surgical contraindications 1. The 2024 AHA/ACC guidelines emphasize that surgical myectomy should be "the first consideration for the majority of eligible patients" 1.

Never perform septal reduction therapy outside a dedicated HCM program—this is explicitly classified as harmful 1, 2. Referral to experienced centers is mandatory even if it requires patient travel 1.

Age considerations are critical: The procedure should not be performed in patients <21 years and is discouraged in adults <40 years when myectomy is viable 1, 2. This reflects concerns about long-term arrhythmogenic potential of the ablation scar in younger patients 5.

Expected Outcomes at Experienced Centers

When performed appropriately, alcohol septal ablation achieves 2, 6:

• 30-day mortality ≤1%
• Permanent pacemaker requirement ≤10% (complete heart block is the most common complication) 4, 5
• Symptomatic improvement ≥1 NYHA class in >90%
• LVOT gradient reduction to <50 mmHg in >90%
• Repeat procedure rate ≤10%

Practical Algorithm for Decision-Making

1. Confirm diagnosis and severity: Document LVOT gradient ≥50 mmHg with provocation if not present at rest 1

2. Optimize medical therapy first: Maximize beta-blockers, verapamil, or disopyramide; consider mavacamten if available 1, 6

3. Assess symptom severity: Proceed only if NYHA class III-IV (or class II with additional high-risk features) despite optimal therapy 1, 3

4. Evaluate surgical candidacy: If patient is <40 years, good surgical candidate, or has concomitant cardiac disease requiring surgery → refer for myectomy 1

5. If surgery contraindicated/high-risk: Confirm adequate septal thickness (<30 mm preferred), refer to experienced HCM center for alcohol septal ablation 1, 2

6. Shared decision-making: For patients who could undergo either procedure, provide balanced counseling and respect patient preference after thorough discussion 1

Consultation with centers experienced in both myectomy and ablation is reasonable to ensure patients receive comprehensive evaluation of all treatment options 1.